Atavistik Bio is using the cash to develop “allosteric” medicines it believes can offer precise impact on diseases like ...

A multicenter research effort yielded findings that may allow for more effective and personalized treatment of an underrecognized but serious blood disorder.Extended follow-up of individuals with ...

Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder that affects the blood vessels. A person with HHT may have blood vessels that have not developed properly and may have no ...

Tectonic Therapeutic (NASDAQ:TECX) used a virtual key opinion leader (KOL) event to outline its strategy for hereditary ...

PITTSBURGH (KFSN) -- HHT is a genetic disorder of the blood vessels. In severe cases, it can lead to sudden bleeding or stroke. Researchers say HHT affects more than one in 5,000 people, but 90 ...

Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a rare, but serious, genetic disorder that causes abnormal blood vessels to form throughout the body. These ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug called pomalidomide, which is used to treat bone marrow ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. ST. LOUIS – A new, highly-specialized, ...

LAFFAYETTE, NJ – A local family has taken their personal story and turned it into a fundraising event. Sparta High School Athletic Director Steve Stoner’s uncle has a blood disorder known as HHT. They ...